Guidelines for good pharmacoepidemiology practices (GPP)

Pharmacoepidemiology and Drug Safety

Volumn 17, Issue 2, 2008, Pages 200-208

  Epstein, Mark ^a  

^a International Society of Pharmacoepidemiology (ISPE)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; CONFIDENTIALITY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; GOOD CLINICAL PRACTICE; HUMAN; INFORMATION DISSEMINATION; INFORMATION PROCESSING; MEDICAL RESEARCH; NOTE; PHARMACOEPIDEMIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRIVACY; PROTECTION; QUALITY CONTROL; RESEARCH ETHICS; RISK ASSESSMENT; RISK MANAGEMENT; STATISTICAL ANALYSIS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; COMMUNICATION; DATA COLLECTION; EPIDEMIOLOGIC METHODS; HUMANS; PHARMACOEPIDEMIOLOGY; SOCIETIES;

EID: 39749089389     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1471     Document Type: Note

References (2)

1. Chemical Manufacturers Association's Epidemiology Task Group. Guidelines for good epidemiology practices for occupational environmental epidemiologic research. J Occup Med 1991; 33: 1221-1229.
2. Austin MA, Ordovas JM, Eckfeldt JH, et al. Guidelines of the National Heart, Lung, and Blood Institute Working Group on Blood Drawing, Processing, and Storage for Genetic Studies. Am J Epidemiol 1996; 144: 437-441.